Division of Thyroid Surgery, Jilin Provincial Key Laboratory of Surgical Translational Medicine, Jilin Provincial Precision Medicine Laboratory of Molecular Biology and Translational Medicine on Differentiated Thyroid Carcinoma, The China-Japan Union Hospital of Jilin University, 126 Xiantai Street, Changchun City, 130033, Jilin Province, China.
Division Of Laboratory Medicine Center, The China-Japan Union Hospital of Jilin University, Changchun City, Jilin Province, China.
Diagn Pathol. 2021 Oct 25;16(1):92. doi: 10.1186/s13000-021-01150-y.
Fine-needle aspiration cytology (FNAC) is a basic diagnostic tool for thyroid nodules. However, 15-30% of nodules are cytologically indeterminate. Midkine (MK), a pleiotropic growth factor, is often upregulated in patients with cancers. This study aimed to evaluate the role of MK and its ratios in fine-needle aspirates (FNA) for predicting thyroid malignancy.
This retrospective study included patients with thyroid nodules who underwent preoperative FNA and/or thyroidectomy between April 2017 and September 2017. MK levels in FNA washout were measured by enzyme-linked immunosorbent assay, and thyroglobulin (TG) and free thyroxine (FT4) levels in FNA washout were measured by chemiluminescent immunometric assays.
A total of 217 patients with 242 nodules were included in this study. The concentrations of TG, FT4, MK/TG, MK/FT4, and FT4/MK were significantly different between papillary thyroid carcinomas and benign thyroid nodules. Both MK/TG and MK/FT4 ratios were positively correlated with maximum tumor diameter, extrathyroidal extension, and T and N stages. The area under the curve for MK/TG was 0.719 with a cutoff value of 55.57 ng/mg, while the area under the curve for MK/FT4 was 0.677 with a cutoff value of 0.11 μg/pmol. FNAC in combination with MK/FT4 had a higher sensitivity (95% vs. 91%) and accuracy (96% vs. 92%) than FNAC alone for cytologically indeterminate specimens, those of unknown significance, or those suspected of malignancy.
MK/FT4 and MK/TG may have diagnostic utility for evaluation of papillary thyroid carcinomas, particularly for cytologically indeterminate thyroid nodules.
细针穿刺细胞学检查(FNAC)是甲状腺结节的基本诊断工具。然而,15-30%的结节细胞学检查结果不确定。中期因子(MK)是一种多效生长因子,在癌症患者中常上调。本研究旨在评估 MK 及其比值在细针抽吸物(FNA)中预测甲状腺恶性肿瘤的作用。
本回顾性研究纳入了 2017 年 4 月至 2017 年 9 月期间接受术前 FNA 和/或甲状腺切除术的甲状腺结节患者。通过酶联免疫吸附试验测量 FNA 洗脱液中的 MK 水平,并通过化学发光免疫测定法测量 FNA 洗脱液中的甲状腺球蛋白(TG)和游离甲状腺素(FT4)水平。
本研究共纳入 217 例 242 个结节患者。乳头状甲状腺癌与良性甲状腺结节之间的 TG、FT4、MK/TG、MK/FT4 和 FT4/MK 浓度差异有统计学意义。MK/TG 和 MK/FT4 比值均与最大肿瘤直径、甲状腺外侵犯、T 和 N 分期呈正相关。MK/TG 的曲线下面积为 0.719,截断值为 55.57ng/mg,而 MK/FT4 的曲线下面积为 0.677,截断值为 0.11μg/pmol。FNAC 联合 MK/FT4 对细胞学不确定、意义不明或疑似恶性的标本的敏感性(95%比 91%)和准确性(96%比 92%)均高于单独 FNAC。
MK/FT4 和 MK/TG 可能对评估甲状腺乳头状癌具有诊断价值,特别是对细胞学不确定的甲状腺结节。